GHK-Cu has shown protective effects on cartilage and bone cells in vitro, suggesting potential in joint or bone healing
Learn more: Read our full guide on GHK-Cu peptide therapy #2 GHK-Cu Injectable Systemic Copper Peptide Delivery What it does: While topical GHK-Cu works at the scalp, injectable GHK-Cu delivers copper peptide benefits systemically
Low and elevated KLOW dose adjustments Low Dose: 1.6 mg total contains 1 mg GHK-Cu and 200 mcg each of BPC-157, TB-4, and KPV
Yes, the human clinical trial evidence is lacking, but there is a silver lining emerging from years of self-experimentation
Next step If the topic still fits your goal after reading, the get-started flow should collect the clinical context needed for provider review
The Shannon Clinic Melbourne has you covered